These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3424216

  • 1. TC-83 Venezuelan equine encephalitis vaccine exposure during pregnancy.
    Casamassima AC, Hess LW, Marty A.
    Teratology; 1987 Dec; 36(3):287-9. PubMed ID: 3424216
    [Abstract] [Full Text] [Related]

  • 2. Congenital cerebral and ocular malformations induced in rhesus monkeys by Venezuelan equine encephalitis virus.
    London WT, Levitt NH, Kent SG, Wong VG, Sever JL.
    Teratology; 1977 Dec; 16(3):285-5. PubMed ID: 413204
    [Abstract] [Full Text] [Related]

  • 3. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS, Lind CM, Lackemeyer MG, Sullivan LJ, Pratt WD, Parker MD.
    Vaccine; 2005 May 02; 23(24):3139-47. PubMed ID: 15837213
    [Abstract] [Full Text] [Related]

  • 4. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.
    Burke DS, Ramsburg HH, Edelman R.
    J Infect Dis; 1977 Sep 02; 136(3):354-9. PubMed ID: 903673
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB, Davis BK, Zhou XD, Chen SJ, Finkelman FD, Gause WC.
    Virology; 1997 Jul 07; 233(2):302-12. PubMed ID: 9217054
    [Abstract] [Full Text] [Related]

  • 6. Radial haemolysis in gel used in serological studies on Venezuelan equine encephalomyelitis virus.
    Gaidamovich SY, Melnikova EE, Obukhova VR.
    Acta Virol; 1981 Jan 07; 25(1):36-40. PubMed ID: 6112864
    [Abstract] [Full Text] [Related]

  • 7. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL, Roberts BA, Terpening SJ, Mott J, Vasconcelos D, House RV.
    Vaccine; 2008 Jun 25; 26(27-28):3497-506. PubMed ID: 18508163
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine.
    Sampson GR, Elliston NG, Miyat JA, Grueter HP, Gillespie JR, Rathmacher RP.
    Mod Vet Pract; 1973 Aug 25; 54(8):19, 21-2. PubMed ID: 4803525
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of the serological reponse of cattle infected naturally and experimentally with Venezuelan equine encephalitis virus].
    Gallo de la Torre M, Bautista Garfias CR, Zárate ML, Rosales Ortega C, Morilla González A.
    Bol Oficina Sanit Panam; 1979 Jan 25; 86(1):10-9. PubMed ID: 154334
    [No Abstract] [Full Text] [Related]

  • 13. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL, Roberts BA, Teehee ML, Terpening SJ, Kelly CL, Raetz JL, Baker DC, Powers AM, Bowen RA.
    Vaccine; 2007 Feb 26; 25(10):1868-76. PubMed ID: 17240002
    [Abstract] [Full Text] [Related]

  • 14. [The postvaccinal reaction in hamadryas baboons to the administration of attenuated strain 15 of the Venezuelan equine encephalomyelitis virus].
    Filatenkov AG, Khaltaeva GG, Lukin EP, Gorban' SG, Khamitova MF, Shkurnikova NN.
    Biull Eksp Biol Med; 1991 Mar 26; 111(3):287-90. PubMed ID: 2054507
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant effects of the lipid amine CP-20,961.
    Anderson AO, Reynolds JA.
    J Reticuloendothel Soc; 1979 Dec 26; 26(Suppl):667-80. PubMed ID: 522085
    [No Abstract] [Full Text] [Related]

  • 16. [Teratogenic effect of the Venezuelan equine encephalitis virus: a review of the problem].
    García-Tamayo J.
    Invest Clin; 1992 Dec 26; 33(2):81-6. PubMed ID: 1457535
    [Abstract] [Full Text] [Related]

  • 17. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
    Turell MJ, O'Guinn ML, Parker MD.
    Am J Trop Med Hyg; 2003 Feb 26; 68(2):218-21. PubMed ID: 12641414
    [Abstract] [Full Text] [Related]

  • 18. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
    Elvin SJ, Bennett AM, Phillpotts RJ.
    J Med Virol; 2002 Jul 26; 67(3):384-93. PubMed ID: 12116032
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.
    Kowalski J, Adkins K, Gangolli S, Ren J, Arendt H, DeStefano J, Obregon J, Tummolo D, Natuk RJ, Brown TP, Parks CL, Udem SA, Long D.
    Vaccine; 2007 Mar 08; 25(12):2296-305. PubMed ID: 17239997
    [Abstract] [Full Text] [Related]

  • 20. Transmissibility of an attenuated Venezuelan equine encephalomyelitis vaccine virus.
    Taylor WM, Buff E.
    J Am Vet Med Assoc; 1972 Jul 15; 161(2):159-63. PubMed ID: 4402529
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.